Biblio
Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Cell Transplant. 2023;32:9636897231183559.
Identification of the microRNA alterations in extracellular vesicles derived from human haemorrhoids. Exp Physiol. 2023.
. Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers. J Vis Exp. 2023;(197).
. Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients. Front Immunol. 2023;14:1173320.
. Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway. Metab Brain Dis. 2023.
MiR-7-5p/KLF4 signaling inhibits stemness and radioresistance in colorectal cancer. Cell Death Discov. 2023;9(1):42.
Neurobiological insights into lower urinary tract dysfunction: evaluating the role of brain-derived neurotrophic factor. Am J Clin Exp Urol. 2023;11(6):559-577.
. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation. Bone Marrow Transplant. 2023.
. Stem-loop RT-qPCR system for multiplex miRNA profiling and its application in wound healing-specific biomarker identification. Anal Biochem. 2023:115267.
. Beyond waste: understanding urine's potential in precision medicine. Trends Biotechnol. 2024.
. Exosomes From Human Umbilical Cord Stem Cells Suppress Macrophage-to-myofibroblast Transition, Alleviating Renal Fibrosis. Inflammation. 2024.
Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing. J Biomed Sci. 2024;31(1):47.
. Human Endometrium Derived Mesenchymal Stem Cells with Aberrant NOD1 Expression Are Associated with Ectopic Endometrial Lesion Formation. Int J Stem Cells. 2024.
. Insights into optimizing exosome therapies for acute skin wound healing and other tissue repair. Front Med. 2024.
. Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial. BMC Med. 2024;22(1):85.
A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2024.